EMAGIX INC.
$74,880.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2025-2026
- Agreement period
- October 1, 2025 – January 15, 2027
- Reference
- nrc-cnrc:172-2025-2026-Q2-1034864
Published purpose
Leaky blood vessels in the retina are the main cause of vision loss in diseases like age-related macular degeneration and diabetic retinopathy – which collectively affect 380 million individuals worldwide. While there are drugs that can stop retinal leakage, the most reliable test for detecting it involves an injection of dye and necessitates emergency readiness in case of an allergic reaction. Hence, this test is invasive, complex, costly, and infrequently used. To address this challenge, we propose an innovative artificial intelligence (AI) approach that will simulate the invasive test from a non-invasive, injection-free photograph commonly collected in routine eye exams.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.